ACU-0943
/ Aculeus Therap, Canthera Discovery
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 12, 2026
ACU SMALL MOLECULE STING AGONISTS DEMONSTRATE TP53-INDEPENDENT ANTI-LEUKAEMIC ACTIVITY AND VENETOCLAX SYNERGY IN ACUTE MYELOID LEUKAEMIA
(EHA 2026)
- "Aims To investigate the preclinical activity of ACU STING agonists (ACU2086 and ACU0943) against AML. These data highlight the potential of ACU STING agonists as a novel treatment for AML and provide preclinical evidence supporting a planned phase 1 clinical trial. Figure 1"
IO biomarker • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Solid Tumor • PTPRC • STING • TP53
1 to 1
Of
1
Go to page
1